Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice.

Melanin concentrating hormone (MCH) is a cyclic neuropeptide expressed in the lateral hypothalamus that plays an important role in energy homeostasis. To investigate the pharmacological consequences of inhibiting MCH signaling in murine obesity models, we examined the effect of acute and chronic administration of a selective MCH1 receptor antagonist (SCH-A) in diet-induced obese (DIO) and Lep(ob/ob) mice. Oral administration of SCH-A for 5 consecutive days (30 mg/kg q.d.) produced hypophagia, a loss of body weight and adiposity, and decreased plasma leptin levels in DIO mice, and hypophagia and reduced weight gain in Lep(ob/ob) mice. Chronic administration of SCH-A to DIO mice decreased food intake, body weight and adiposity, and plasma leptin and free fatty acids. These effects were accompanied by increases in several hypothalamic neuropeptides. Acute administration of SCH-A (30 mg/kg) prevented the decrease in energy expenditure associated with food restriction. These results indicate that MCH1 receptor antagonists may be effective in the treatment of obesity.

[1]  J. Flier,et al.  Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  D. Richter,et al.  Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan somatostatin‐like receptor 1 (SLC‐1) , 1999, FEBS letters.

[3]  M. Bednarek,et al.  Antiobesity effect of a melanin-concentrating hormone 1 receptor antagonist in diet-induced obese mice. , 2005, Endocrinology.

[4]  T Watanabe,et al.  Cloning of a novel G protein-coupled receptor, SLT, a subtype of the melanin-concentrating hormone receptor. , 2001, Biochemical and biophysical research communications.

[5]  Yue Feng,et al.  Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Fanghänel,et al.  Second phase of a double-blind study clinical trial on Sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-over , 2001, International Journal of Obesity.

[7]  H. Hsiung,et al.  Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. , 2002, Endocrinology.

[8]  J. Chambers,et al.  Molecular Cloning and Functional Characterization of MCH2, a Novel Human MCH Receptor* , 2001, The Journal of Biological Chemistry.

[9]  Ruo Xu,et al.  Discovery of bicycloalkyl urea melanin concentrating hormone receptor antagonists: orally efficacious antiobesity therapeutics. , 2005, Journal of medicinal chemistry.

[10]  E. Grazzini,et al.  The receptor for the orexigenic peptide melanin-concentrating hormone is a G-protein-coupled receptor , 1999, Nature Cell Biology.

[11]  M. Bednarek,et al.  Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats. , 2003, European journal of pharmacology.

[12]  Robin Shapiro,et al.  Identification of 2-(4-benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesity. , 2005, Journal of medicinal chemistry.

[13]  B. Hawes,et al.  Cloning and characterization of rhesus monkey MCH-R1 and MCH-R2 , 2002, Peptides.

[14]  C. Austin,et al.  Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression. , 2002, Genomics.

[15]  H. Iwaasa,et al.  Chronic intracerebroventricular infusion of MCH causes obesity in mice. Melanin-concentrating hormone. , 2003, American journal of physiology. Endocrinology and metabolism.

[16]  B. Baker.  Melanin-concentrating hormone: a general vertebrate neuropeptide. , 1991, International review of cytology.

[17]  J. Chambers,et al.  Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1 , 1999, Nature.

[18]  P. Sawchenko,et al.  The rat melanin-concentrating hormone messenger ribonucleic acid encodes multiple putative neuropeptides coexpressed in the dorsolateral hypothalamus. , 1989, Endocrinology.

[19]  S. Gammeltoft,et al.  A role for melanin-concentrating hormone in the central regulation of feeding behaviour , 1996, Nature.

[20]  O. Nishimura,et al.  Isolation and identification of melanin-concentrating hormone as the endogenous ligand of the SLC-1 receptor. , 1999, Biochemical and biophysical research communications.

[21]  T. Kowalski,et al.  Transgenic overexpression of neuromedin U promotes leanness and hypophagia in mice. , 2005, The Journal of endocrinology.

[22]  B. Hawes,et al.  The melanin-concentrating hormone receptor couples to multiple G proteins to activate diverse intracellular signaling pathways. , 2000, Endocrinology.

[23]  J. Boutin,et al.  Cloning and molecular characterization of the novel human melanin-concentrating hormone receptor MCH2. , 2001, Molecular pharmacology.

[24]  B. Lowell,et al.  Mice lacking melanin-concentrating hormone are hypophagic and lean , 1998, Nature.

[25]  C. Broberger.  Hypothalamic cocaine- and amphetamine-regulated transcript (CART) neurons: histochemical relationship to thyrotropin-releasing hormone, melanin-concentrating hormone, orexin/hypocretin and neuropeptide Y , 1999, Brain Research.

[26]  Beth Borowsky,et al.  Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist , 2002, Nature Medicine.

[27]  F. Leslie,et al.  Expression of the melanin‐concentrating hormone (MCH) receptor mRNA in the rat brain , 2001, The Journal of comparative neurology.

[28]  E. Mathus-Vliegen,et al.  Dexfenfluramine in the treatment of severe obesity: a placebo‐controlled investigation of the effects on weight loss, cardiovascular risk factors, food intake and eating behaviour , 1992, Journal of internal medicine.

[29]  Yuji Ishihara,et al.  T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist. , 2002, European journal of pharmacology.

[30]  W Li,et al.  Identification and characterization of a melanin-concentrating hormone receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  C. Bailey,et al.  Anorectic effect of metformin in lean and genetically obese hyperglycaemic (ob/ob) mice. , 1986, Archives internationales de pharmacodynamie et de therapie.

[32]  Christopher P. Austin,et al.  Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Heiman,et al.  Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis. , 2004, Obesity research.

[34]  A. Viale,et al.  The melanin-concentrating hormone gene in human: flanking region analysis, fine chromosome mapping, and tissue-specific expression. , 1997, Brain research. Molecular brain research.

[35]  B. Lowell,et al.  Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. , 2001, The Journal of clinical investigation.

[36]  C. Bailey,et al.  Anorectic effect of fenfluramine, cholecystokinin and neurotensin in genetically obese (ob/ob) mice. , 1986, Comparative biochemistry and physiology. A, Comparative physiology.

[37]  C. Saper,et al.  Characterization of CART neurons in the rat and human hypothalamus , 2001, The Journal of comparative neurology.

[38]  J. Vaughan,et al.  The melanin‐concentrating hormone system of the rat brain: An immuno‐ and hybridization histochemical characterization , 1992, The Journal of comparative neurology.

[39]  Yumiko Saito,et al.  Molecular characterization of the melanin-concentrating-hormone receptor , 1999, Nature.

[40]  B. Hawes,et al.  Identification and Pharmacological Characterization of a Novel Human Melanin-concentrating Hormone Receptor, MCH-R2* , 2001, The Journal of Biological Chemistry.

[41]  P. J. Larsen,et al.  Hypothalamic CART is a new anorectic peptide regulated by leptin , 1998, Nature.

[42]  S. Shioda,et al.  Reciprocal synaptic relationships between orexin- and melanin-concentrating hormone-containing neurons in the rat lateral hypothalamus: a novel circuit implicated in feeding regulation , 2002, International Journal of Obesity.

[43]  C. Day,et al.  Effect of the antiobesity agent sibutramine in obese-diabetic ob/ob mice , 1998, International Journal of Obesity.

[44]  H. Iwaasa,et al.  Characterization of MCH-mediated obesity in mice. , 2003, American journal of physiology. Endocrinology and metabolism.